Calendar of CURE/Yale BioHaven seminars for Fall 2010 now available. more
9/14
8:45 am - 6:00 pm

Ubifrance, the French Agency for international business development, cordially invites CURE members to this year's second French Biotech Tour, which aims to connect French and American Biotech companies specialized in neuroscience, inflammation, and auto-immune diseases. Philadelphia, PA. more
9/16
6:00 pm - 7:30 pm

CURE/Yale BioHaven presents Al Mann: 'Creating a successful medical device enterprise.' Hope Auditorium, Yale University, 315 Cedar Street, New Haven. more
10/5
Deadline for nominations for the Lemelson-MIT prize, awarded to an outstanding mid-career inventor who has developed a patented product or process of significant value to society. more
10/14
4:00 pm - 7:00 pm

Hartford Hospital Research Symposium. 'Personalized Medicine and Genomics: The Future is Now.' RSVP by 10/1 to 860.545.5620. Heublein Hall, Education & Resource Center, Hartford Hospital, Hudson Street, Hartford. more
10/27
4:00 pm - 6:00 pm

CURE/Yale BioHaven presents Cobalt Therapeutics. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more
11/18
4:00 pm - 6:00 pm

CURE/Yale BioHaven presents Biodel Inc. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more
12/7
5:30 pm - 7:30 pm

CURE Holiday Party. Café George, 300 George Street, New Haven. Watch for details.


Cheminpharma LLC
25 Science Park at Yale
150 Munson Street
New Haven, CT 08511

Phone: 203-773-1737
Website: http://www.cheminpharma.com

General Information
Connecticut, especially the New Haven area, is home to various biotechnology and pharmaceutical companies surrounding Yale University. Due to the complexity and increasing cost of drug-discovery research, outsourcing a part of research is becoming a normal trend in today's rapidly changing pharmaceutical environment. Therefore, there is a need for a world-class research support company in the region. Cheminpharma intends to fill this gap. Cheminpharma is a drug discovery services company formed by two former Bayer scientists. The founders have twenty-eight years of combined experience in drug discovery research in various therapeutic areas including cancer, diabetes, obesity, osteoporosis, and inflammation. Cheminpharma provides various chemistry based services for preclinical drug discovery to both biotechnology and pharmaceutical companies using their state-of-the art facility. The services include medicinal chemistry services such as hit to lead generation, analog design, lead optimization, building SAR, and structure-based drug design. In addition to medicinal chemistry services, Cheminpharma provides synthesis of intermediates, reference compounds, process impurities etc.

Other Information
CT Employees: 3

Back